Efficacy and side-effects of oral contraceptives.
- Published in:
- Prescriber, 2017, v. 28, n. 8, p. 19, doi. 10.1002/psb.1600
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2017 AND VI 28 AND IP 8
Results: 9
1
2
Brexit means Brexit, but what of pharmacovigilance?
- Published in:
- Prescriber, 2017, v. 28, n. 8, p. 27, doi. 10.1002/psb.1601
- By:
- Publication type:
- Article
3
Tofacitinib: a janus kinase inhibitor for rheumatoid arthritis.
- Published in:
- Prescriber, 2017, v. 28, n. 8, p. 30, doi. 10.1002/psb.1602
- By:
- Publication type:
- Article
4
Diagnosis and management of spondyloarthritis in the over-16s.
- Published in:
- Prescriber, 2017, v. 28, n. 8, p. 33, doi. 10.1002/psb.1603
- By:
- Publication type:
- Article
5
Will the UK face an opioid abuse epidemic?
- Published in:
- Prescriber, 2017, v. 28, n. 8, p. 36, doi. 10.1002/psb.1604
- By:
- Publication type:
- Article
6
Prescription for disaster.
- Published in:
- Prescriber, 2017, v. 28, n. 8, p. 39, doi. 10.1002/psb.1605
- By:
- Publication type:
- Article
7
Pharma, the NHS and our learned friends.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
8
How will NICE's budget impact test affect new drug availability?
- Published in:
- Prescriber, 2017, v. 28, n. 8, p. 9, doi. 10.1002/psb.1598
- By:
- Publication type:
- Article
9
Administering steroids with HIV treatment-boosting agents.
- Published in:
- Prescriber, 2017, v. 28, n. 8, p. 13, doi. 10.1002/psb.1599
- By:
- Publication type:
- Article